Seòmar agus comataidhean

The endometriosis care pathway for NHS Scotland aims to support healthcare professionals to provide a holistic approach and timely care for those with endometriosis and endometriosis-like symptoms. The pathway ensures that healthcare professionals are considering women’s need for and access to pain management. All NHS Boards should be taking steps to implement the pathway.

Through the Women’s Health Plan we have developed the Women’s Health Platform on NHS Inform which includes an endometriosis page with consistent, reliable and accessible information, including a lived experience film, empowering women to make informed decisions about their health.

To increase the information available to women, we funded Endometriosis UK to produce a booklet and two webinars on treatments and self-management tips for managing endometriosis pain.

More information is available in the Women’s Health Plan Final Report.

We are committed to ensuring those living with endometriosis are able to access the best possible care and support and that they benefit from healthcare services that are safe, effective and put people at the centre of their care. Endometriosis will continue to be a priority as we develop the next phase of our Women’s Health Plan.

The Endometriosis Care Pathway for Scotland, adapted from NICE guidance, provides a streamlined integrated primary, secondary and tertiary care pathway aimed at providing a holistic approach and timely care for those with endometriosis and endometriosis-like symptoms.

The Scottish National Menstrual Health Specialist Network provides healthcare professionals with a special interest in menstrual health a forum for peer support and sharing expert clinical advice and best practice related to menstrual health symptoms and conditions.

We will build on the progress set out in the Women’s Health Plan 2021 - 2024 Final Report, as we work towards ensuring those living with endometriosis are able to access the best possible care and support and that they benefit from healthcare services that are safe, effective and put people at the centre of their care.

This information is not held centrally.

As of December 2024 there have been:

• Almost 65,000 users on the life sections
• Over 986,000 views on the Periods pages
• Just under 3.2 million views on the Menopause pages

The public consultation on the detail of proposed regulations to restrict promotions of food and drink high in fat, sugar or salt closed on 21 May 2024.

We will publish the independent analysis report of the consultation responses in early 2025, as well as next steps and timelines for the regulation of HFSS food and drink promotions.

The costs associated with establishing an identity for Qualifications Scotland were set out in the Financial Memorandum that accompanied the Education (Scotland) Bill and were the best estimate available at the time.

A cost relating to the creation of an identity of a new public body will always be incurred and Qualifications Scotland is no exception. I requested that my officials look at ways to bear down on costs where possible while still delivering an identity for Qualifications Scotland. I can confirm that officials have been working closely with the SQA on this, to ensure that value for money for taxpayers is achieved.

The Scottish Government is aware of concerns that have been raised around online alcohol sales in Scotland. Officials are engaging with industry and business stakeholders to better understand these concerns and continue to keep the potential impact of this developing market under review.

Public Health Scotland holds alcohol retail sales data for both the on-trade and off-trade, which includes all electronic point of sale data for the main supermarkets and a representative sample of smaller retailers and independent stores. This data includes alcohol purchased online from larger national supermarkets which is processed on premises. Detailed information on cross-border online alcohol sales is not available and such information is likely to be commercially confidential and would require businesses to supply this on a voluntary basis.

We are committed to ensuring those living with endometriosis are able to access the best possible care and support and that they benefit from healthcare services that are safe, effective and put people at the centre of their care.

Through the delivery of the Women’s Health Plan we have worked to ensure that women have access to comprehensive information on endometriosis – including options for treatment.

We have; launched a Women’s Health Platform on NHS Inform which includes an endometriosis page with consistent, reliable and accessible information, including a short lived experience film, empowering women to make informed decisions about their health; worked with organisations such as the Health and Social Care Alliance Scotland, Young Scot and Endometriosis UK to raise awareness about the condition and deliver accurate and supportive information to the public; funded Endometriosis UK to produce a booklet and two webinars on treatments and self-management tips for managing endometriosis pain.

More information can be found in the Women’s Health Plan Final Report.

The figures below relate to Endometriosis research funding directly awarded following a competitive independent review process either through Chief Scientist Office’s (CSO) project funding committees, or fellowship funding panels.

This includes the 2022 Scottish Government collaboration with Wellbeing of Women on a £250,000 research call. The research is primarily being run by researchers at The University of Edinburgh and will look at a non-hormonal drug in the management of endometriosis-associated pain.

Most awards are multi-year. The figures below relate to the year in which the funding was committed rather than a breakdown by year of the spend profile for individual projects or fellowships

2007 0

2008 0

2009 0

2010 0

2011 0

2012 £110,198

2013 0

2014 0

2015 £27,639

2016 0

2017 0

2018 £162,651

2019 £30,000

2020 0

2021 0

2022 £394,510

2023 £349,999

2024 £623,028

Full details of CSO’s direct research funding awards are available from the CSO website Funded Research – Chief Scientist Office

The Scottish Government provides baseline funding to NHS Boards, which Boards use to best meet the healthcare needs of their resident population. Funding is not ring-fenced for the treatment of endometriosis. It is not therefore possible to identify funding allocated specifically for endometriosis.

Through the Women’s Health Plan, a range of funding has been provided for resources and research related to improving endometriosis care.

The Scottish Government collaborated with Wellbeing of Women on a £250,000 research call in 2022. The research is primarily being run by researchers at The University of Edinburgh and will look at a non-hormonal drug in the management of endometriosis-associated pain.

The Chief Scientist Office announced funding of £299,509 for the 30 month ENDOCAN project in January 2023, led by researchers at The University of Edinburgh. Through a large scale UK-wide trial, the research will investigate whether a cannabinoid can reduce endometriosis-associated pain.

The Scottish Government also provided £24,000 of funding in August 2023 to Endometriosis UK to deliver a project creating new resources to support people with endometriosis.

The Health and Social Care Alliance Scotland (the ALLIANCE) has continued to support the Women’s Health Plan through their dedicated lived experience programme, including a Women’s Health Lived Experience Stakeholder Group, to help us continue our conversation with women, and ensure women are meaningfully involved in decision making and priority setting going forward.

More information can be found in the ALLIANCE Final Report on Women’s Health Plan.